Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood Glucose Levels After Knee Steroid Injection in Diabetic Patients
NCT06228911Completed
- Sponsor
- Syrian Private University
- Start
- Jan 2020
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of triamcinolone acetonide in osteoarthritis (OA) (2 arms), sponsored by Syrian Private University. Primary endpoints: High blood glucose at 3 years and Low blood glucose at 3 years. Started Jan 2020; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06228911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06228911.